Kerry Jefferson is an accomplished legal professional with extensive experience in corporate transactions within the pharmaceutical and biotechnology sectors. Kerry served as Executive Director of Corporate Transactions at Merck from April 2019 to April 2021, where leadership was provided to a team of attorneys and paralegals in supporting strategic M&A and licensing arrangements. Prior to this role, Kerry held various positions at Sandoz, including Director & Associate General Counsel, where legal support was provided for business development transactions. Additional experience includes a Senior Associate role at Morgan, Lewis & Bockius LLP, focusing on advising life sciences clients on complex transactions. Kerry also practiced as an Associate at Seyfarth Shaw LLP and was a Summer Associate at Pfizer. Academic credentials include a Doctor of Law (J.D.) from Fordham University School of Law and a B.S. in Computer Information Systems from Arizona State University.
This person is not in any teams
This person is not in any offices